Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
What You Missed On Wall Street This Morning » 12:22
10/04/22
10/04
12:22
10/04/22
12:22
TWTR

Twitter

$45.40 /

+2.81 (+6.60%)

, TSLA

Tesla

$251.33 /

+9.055 (+3.74%)

, POSH

Poshmark

$17.64 /

+2.07 (+13.29%)

, MU

Micron

$54.68 /

+2.98 (+5.76%)

, BA

Boeing

$132.52 /

+6.49 (+5.15%)

, F

Ford

$12.21 /

+0.735 (+6.41%)

, PARA

Paramount

$19.99 /

+0.37 (+1.89%)

, DPZ

Domino's Pizza

$331.69 /

+15.34 (+4.85%)

, GILD

Gilead

$64.57 /

+2.24 (+3.59%)

, AMZN

Amazon.com

$122.53 /

+6.62 (+5.71%)

, UBER

Uber

$28.53 /

+1.84 (+6.89%)

, COMM

CommScope

$11.04 /

+1.48 (+15.48%)

, HNHPF

Hon Hai Precision

$6.27 /

-0.08 (-1.26%)

, AAPL

Apple

$145.18 /

+2.735 (+1.92%)

, BABA

Alibaba

$84.22 /

+3.82 (+4.75%)

, TCEHY

Tencent

$33.80 /

-0.02 (-0.06%)

, BBBY

Bed Bath & Beyond

$6.43 /

+0.44 (+7.35%)

, INBX

Inhibrx

$27.01 /

+6.85 (+33.98%)

, RIVN

Rivian Automotive

$35.75 /

+3.865 (+12.12%)

, CORZ

Core Scientific

$1.60 /

+0.22 (+16.00%)

, KALV

KalVista

$6.42 /

-7.86 (-55.04%)

, MRVI

Maravai Lifesciences

$22.34 /

-2.42 (-9.77%)

, HAS

Hasbro

$69.05 /

+0.09 (+0.13%)

, AXTI

AXT Inc.

$5.72 /

-1.28 (-18.29%)

, AYI

Acuity Brands

$169.74 /

+10.35 (+6.49%)

, REBN

Reborn Coffee

$1.74 /

+ (+0.00%)

, AEP

American Electric

$90.39 /

+2.16 (+2.45%)

Get caught up quickly on…

ShowHide Related Items >><<
UBER Uber
$28.53 /

+1.84 (+6.89%)

TWTR Twitter
$45.40 /

+2.81 (+6.60%)

TSLA Tesla
$251.33 /

+9.055 (+3.74%)

TCEHY Tencent
$33.80 /

-0.02 (-0.06%)

RIVN Rivian Automotive
$35.75 /

+3.865 (+12.12%)

POSH Poshmark
$17.64 /

+2.07 (+13.29%)

PARA Paramount
$19.99 /

+0.37 (+1.89%)

MU Micron
$54.68 /

+2.98 (+5.76%)

MRVI Maravai Lifesciences
$22.34 /

-2.42 (-9.77%)

KALV KalVista
$6.42 /

-7.86 (-55.04%)

INBX Inhibrx
$27.01 /

+6.85 (+33.98%)

HNHPF Hon Hai Precision
$6.27 /

-0.08 (-1.26%)

HAS Hasbro
$69.05 /

+0.09 (+0.13%)

GILD Gilead
$64.57 /

+2.24 (+3.59%)

F Ford
$12.21 /

+0.735 (+6.41%)

DPZ Domino's Pizza
$331.69 /

+15.34 (+4.85%)

CORZ Core Scientific
$1.60 /

+0.22 (+16.00%)

COMM CommScope
$11.04 /

+1.48 (+15.48%)

BBBY Bed Bath & Beyond
$6.43 /

+0.44 (+7.35%)

BABA Alibaba
$84.22 /

+3.82 (+4.75%)

BA Boeing
$132.52 /

+6.49 (+5.15%)

AYI Acuity Brands
$169.74 /

+10.35 (+6.49%)

AXTI AXT Inc.
$5.72 /

-1.28 (-18.29%)

AMZN Amazon.com
$122.53 /

+6.62 (+5.71%)

AEP American Electric
$90.39 /

+2.16 (+2.45%)

AAPL Apple
$145.18 /

+2.735 (+1.92%)

TWTR Twitter
$45.40 /

+2.81 (+6.60%)

08/24/22 Gordon Haskett
Twitter whistleblower has no 'smoking gun,' says Gordon Haskett
08/24/22 Rosenblatt
Rosenblatt downgrades Twitter on risk of Musk using whistleblower suit
08/24/22 Rosenblatt
Twitter downgraded to Neutral from Buy at Rosenblatt
08/10/22 Gordon Haskett
Tesla sale shows Musk knows must come up with Twitter money, says Gordon Haskett
TSLA Tesla
$251.33 /

+9.055 (+3.74%)

10/04/22 Morgan Stanley
Morgan Stanley expects Tesla shares to give back recent relative strength
10/03/22 JPMorgan
Tesla price target raised to $153 from $137 at JPMorgan
10/03/22 Oppenheimer
Tesla should be bought on any weakness following Q3 deliveries, says Oppenheimer
10/03/22 Wedbush
Wedbush remains bullish onTesla as Q3 deliveries come up short
POSH Poshmark
$17.64 /

+2.07 (+13.29%)

10/04/22 Needham
RealReal may be target for acquisition after Poshmark, says Needham
10/04/22 Wedbush
Poshmark downgraded to Neutral from Outperform at Wedbush
08/15/22 Barclays
Poshmark upgraded to Overweight from Equal Weight at Barclays
07/27/22 MKM Partners
MKM assumes Poshmark with Neutral rating, cites near-term profitability concerns
MU Micron
$54.68 /

+2.98 (+5.76%)

10/04/22 Craig-Hallum
Western Digital price target lowered to $50 from $85 at Craig-Hallum
09/30/22 BMO Capital
Micron price target lowered to $70 from $80 at BMO Capital
09/30/22 Needham
Micron price target lowered to $60 from $64 at Needham
09/30/22 Stifel
Micron price target lowered to $54 from $56 at Stifel
BA Boeing
$132.52 /

+6.49 (+5.15%)

09/27/22 Morgan Stanley
Boeing's China and MAX 10 risks overdone at current levels, says Morgan Stanley
09/23/22 BofA
Losing Xiamen to Airbus another setback for Boeing, says BofA
09/14/22 Jefferies
Woodward downgraded to Hold from Buy at Jefferies
09/08/22 Morgan Stanley
Boeing price target raised to $233 from $215 at Morgan Stanley
F Ford
$12.21 /

+0.735 (+6.41%)

09/30/22 Morgan Stanley
U.S. recession, 'Tesla-friendly' IRA may force change at GM, says Morgan Stanley
09/28/22 Citi
Ford price target lowered to $13 from $16 at Citi
09/21/22 BofA
Lyft takeover speculation 'may be more hype than substance,' says BofA
09/20/22 Morgan Stanley
Morgan Stanley would be buyer on weakness in Ford below $14 per share
PARA Paramount
$19.99 /

+0.37 (+1.89%)

10/04/22 Wells Fargo
Wells Fargo downgrades Paramount on 'crumbling' linear ecosystem
10/04/22 Wells Fargo
Paramount downgraded to Equal Weight from Overweight at Wells Fargo
08/15/22 Benchmark
Nexstar getting 75% stake in CW Network for 'free,' says Benchmark
08/05/22 Deutsche Bank
Paramount price target lowered to $32 from $35 at Deutsche Bank
DPZ Domino's Pizza
$331.69 /

+15.34 (+4.85%)

10/04/22 UBS
Domino's Pizza upgraded to Buy from Neutral at UBS
10/03/22 Oppenheimer
Domino's Pizza price target lowered to $415 from $445 at Oppenheimer
09/27/22 Cowen
Domino's Pizza price target lowered to $362 from $410 at Cowen
09/23/22 Citi
Domino's Pizza price target lowered to $415 from $475 at Citi
GILD Gilead
$64.57 /

+2.24 (+3.59%)

10/04/22 JPMorgan
Gilead upgraded to Overweight from Neutral at JPMorgan
09/20/22 Piper Sandler
Piper says Merck partial hold being lifted a positive update for Gilead
09/15/22 Truist
Gilead price target raised to $76 from $71 at Truist
09/13/22 Wells Fargo
Gilead price target raised to $74 from $63 at Wells Fargo
AMZN Amazon.com
$122.53 /

+6.62 (+5.71%)

10/04/22 JPMorgan
Amazon remains JPMorgan's top internet idea, followed by Uber
10/04/22 BofA
Meta Platforms price target lowered to $196 from $218 at BofA
10/04/22 BofA
Alphabet price target lowered to $114 from $125 at BofA
10/03/22 Morgan Stanley
UPS price target lowered to $100 from $148 at Morgan Stanley
UBER Uber
$28.53 /

+1.84 (+6.89%)

09/26/22 UBS
UBS cuts Lyft to Neutral, sees more 'structural headwinds' relative to Uber
09/12/22 Wedbush
Wedbush raises Wingstop price target to $157, removes from Best Ideas List
09/06/22 BofA
BofA starts Lyft at Underperform with $14 price target
COMM CommScope
$11.04 /

+1.48 (+15.48%)

10/04/22 Credit Suisse
CommScope upgraded to Outperform from Neutral at Credit Suisse
08/05/22 Deutsche Bank
CommScope price target raised to $12 from $9 at Deutsche Bank
08/05/22 Citi
CommScope price target raised to $7 from $6 at Citi
08/05/22 Morgan Stanley
CommScope downgraded to Equal Weight from Overweight at Morgan Stanley
HNHPF Hon Hai Precision
$6.27 /

-0.08 (-1.26%)

03/14/22 BofA
Apple exposure to Shenzhen and Suzhou 'manageable,' says BofA
11/12/21 R.F. Lafferty
R.F. Lafferty upgrades Lordstown to Hold on better odds for Endurance production
AAPL Apple
$145.18 /

+2.735 (+1.92%)

10/03/22 BofA
BofA cuts InterDigital target, says Apple pact doesn't change growth
10/03/22 BWS Financial
AXT Inc. may have won spot in iPhone 14 Pro and Pro Max, says BWS Financial
10/03/22 JPMorgan
JPMorgan survey indicates greater intent to upgrade to iPhone 14
10/03/22 Roth Capital
Roth says InterDigital renewed relationship with Apple should alleviate pressure
BABA Alibaba
$84.22 /

+3.82 (+4.75%)

10/03/22 Barclays
Alibaba price target lowered to $135 from $161 at Barclays
09/30/22 Morgan Stanley
Alibaba price target lowered to $110 from $140 at Morgan Stanley
09/29/22 Citi
Citi cuts Alibaba target but says current share price attractive
08/08/22 Deutsche Bank
Alibaba price target raised to $160 from $155 at Deutsche Bank
TCEHY Tencent
$33.80 /

-0.02 (-0.06%)

09/22/22 Stifel
Ubisoft downgraded to Hold from Buy at Stifel
09/13/22 Goldman Sachs
Tongcheng Travel upgraded to Buy from Neutral at Goldman Sachs
09/07/22 Benchmark
Tencent investment 'not a big deal' for Ubisoft, says Benchmark
08/01/22 Goldman Sachs
Bilibili received one China game approval for August, says Goldman Sachs
BBBY Bed Bath & Beyond
$6.43 /

+0.44 (+7.35%)

09/30/22 Odeon Capital
Odeon upgrades Bed Bath & Beyond to Hold with things 'moving in right direction'
09/30/22 Odeon Capital
Bed Bath & Beyond upgraded to Hold from Sell at Odeon Capital
09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
INBX Inhibrx
$27.01 /

+6.85 (+33.98%)

08/09/22 Credit Suisse
Inhibrx price target lowered to $48 from $53 at Credit Suisse
03/15/22 SMBC Nikko
Inhibrx initiated with an Outperform at SMBC Nikko
03/15/22 SMBC Nikko
Inhibrx initiated with an Outperform at SMBC Nikko
11/10/21 Credit Suisse
Inhibrx price target raised to $53 from $44 at Credit Suisse
RIVN Rivian Automotive
$35.75 /

+3.865 (+12.12%)

10/04/22 Truist
Rivian Automotive's affirmed FY22 production outweighs Q3 shortfall, says Truist
09/28/22 Truist
Truist starts 'diversified mobility powerhouse' Rivian Automotive at Buy
09/28/22 Truist
Rivian Automotive initiated with a Buy at Truist
09/28/22 RBC Capital
RBC cuts Rivian target, production forecasts but stays Outperform
CORZ Core Scientific
$1.60 /

+0.22 (+16.00%)

10/04/22 Barclays
Core Scientific initiated with an Overweight at Barclays
09/27/22 Compass Point
Core Scientific initiated with a Buy at Compass Point
09/16/22 Cowen
Core Scientific price target lowered to $3.75 from $4.00 at Cowen
09/06/22 H.C. Wainwright
Core Scientific initiated with a Buy at H.C. Wainwright
KALV KalVista
$6.42 /

-7.86 (-55.04%)

10/04/22 Piper Sandler
Piper says KalVista setback removes overhang for BioCryst's Orladeyo
06/08/22 Stifel
KalVista acute HAE market opportunity 'underappreciated,' says Stifel
11/10/21 Roth Capital
KalVista FDA meeting feedback 'quite positive,' says Roth Capital
MRVI Maravai Lifesciences
$22.34 /

-2.42 (-9.77%)

08/24/22 Credit Suisse
Maravai Lifesciences initiated with an Outperform at Credit Suisse
08/05/22 Baird
Maravai Lifesciences price target lowered to $34 from $40 at Baird
05/06/22 Baird
Maravai Lifesciences price target lowered to $40 from $48 at Baird
02/28/22 William Blair
Maravai buyout price would need to be well into $50s, says William Blair
HAS Hasbro
$69.05 /

+0.09 (+0.13%)

08/18/22 BofA
Hasbro reinstated with a Buy at BofA
07/21/22 BMO Capital
Hasbro price target lowered to $80 from $85 at BMO Capital
07/20/22 Truist
Hasbro price target lowered to $88 from $100 at Truist
07/15/22 Jefferies
Hasbro price target lowered to $100 from $115 at Jefferies
AXTI AXT Inc.
$5.72 /

-1.28 (-18.29%)

10/04/22 Northland
AXT Inc. price target lowered to $10 from $12 at Northland
10/04/22 B. Riley
AXT Inc. price target lowered to $6.50 from $8 at B. Riley
06/27/22 Needham
AXT Inc. initiated with a Buy at Needham
AYI Acuity Brands
$169.74 /

+10.35 (+6.49%)

09/27/22 William Blair
Acuity survey shows waning impact from price hikes, says William Blair
07/01/22 Oppenheimer
Acuity Brands delivers 'strong organic beat' in Q3, says Oppenheimer
07/01/22 Baird
Acuity Brands price target raised to $190 from $188 at Baird
06/27/22 Credit Suisse
Acuity Brands price target lowered to $211 from $241 at Credit Suisse
REBN Reborn Coffee
$1.74 /

+ (+0.00%)

AEP American Electric
$90.39 /

+2.16 (+2.45%)

10/03/22 BMO Capital
American Electric price target lowered to $96 from $106 at BMO Capital
07/28/22 Citi
American Electric price target raised to $99 from $94 at Citi
04/25/22 Credit Suisse
American Electric initiated with an Outperform at Credit Suisse
03/29/22 Mizuho
American Electric price target raised to $104 from $94 at Mizuho
UBER Uber
$28.53 /

+1.84 (+6.89%)

TWTR Twitter
$45.40 /

+2.81 (+6.60%)

TSLA Tesla
$251.33 /

+9.055 (+3.74%)

RIVN Rivian Automotive
$35.75 /

+3.865 (+12.12%)

REBN Reborn Coffee
$1.74 /

+ (+0.00%)

POSH Poshmark
$17.64 /

+2.07 (+13.29%)

PARA Paramount
$19.99 /

+0.37 (+1.89%)

MU Micron
$54.68 /

+2.98 (+5.76%)

MRVI Maravai Lifesciences
$22.34 /

-2.42 (-9.77%)

KALV KalVista
$6.42 /

-7.86 (-55.04%)

INBX Inhibrx
$27.01 /

+6.85 (+33.98%)

HAS Hasbro
$69.05 /

+0.09 (+0.13%)

GILD Gilead
$64.57 /

+2.24 (+3.59%)

F Ford
$12.21 /

+0.735 (+6.41%)

DPZ Domino's Pizza
$331.69 /

+15.34 (+4.85%)

CORZ Core Scientific
$1.60 /

+0.22 (+16.00%)

COMM CommScope
$11.04 /

+1.48 (+15.48%)

BBBY Bed Bath & Beyond
$6.43 /

+0.44 (+7.35%)

BABA Alibaba
$84.22 /

+3.82 (+4.75%)

BA Boeing
$132.52 /

+6.49 (+5.15%)

AYI Acuity Brands
$169.74 /

+10.35 (+6.49%)

AXTI AXT Inc.
$5.72 /

-1.28 (-18.29%)

AMZN Amazon.com
$122.53 /

+6.62 (+5.71%)

AEP American Electric
$90.39 /

+2.16 (+2.45%)

AAPL Apple
$145.18 /

+2.735 (+1.92%)

  • 12
    Aug
  • 10
    Nov
UBER Uber
$28.53 /

+1.84 (+6.89%)

TWTR Twitter
$45.40 /

+2.81 (+6.60%)

TSLA Tesla
$251.33 /

+9.055 (+3.74%)

TCEHY Tencent
$33.80 /

-0.02 (-0.06%)

RIVN Rivian Automotive
$35.75 /

+3.865 (+12.12%)

POSH Poshmark
$17.64 /

+2.07 (+13.29%)

PARA Paramount
$19.99 /

+0.37 (+1.89%)

MU Micron
$54.68 /

+2.98 (+5.76%)

HNHPF Hon Hai Precision
$6.27 /

-0.08 (-1.26%)

HAS Hasbro
$69.05 /

+0.09 (+0.13%)

F Ford
$12.21 /

+0.735 (+6.41%)

BBBY Bed Bath & Beyond
$6.43 /

+0.44 (+7.35%)

BABA Alibaba
$84.22 /

+3.82 (+4.75%)

BA Boeing
$132.52 /

+6.49 (+5.15%)

AMZN Amazon.com
$122.53 /

+6.62 (+5.71%)

AAPL Apple
$145.18 /

+2.735 (+1.92%)

UBER Uber
$28.53 /

+1.84 (+6.89%)

TWTR Twitter
$45.40 /

+2.81 (+6.60%)

TSLA Tesla
$251.33 /

+9.055 (+3.74%)

TCEHY Tencent
$33.80 /

-0.02 (-0.06%)

RIVN Rivian Automotive
$35.75 /

+3.865 (+12.12%)

REBN Reborn Coffee
$1.74 /

+ (+0.00%)

POSH Poshmark
$17.64 /

+2.07 (+13.29%)

PARA Paramount
$19.99 /

+0.37 (+1.89%)

MU Micron
$54.68 /

+2.98 (+5.76%)

KALV KalVista
$6.42 /

-7.86 (-55.04%)

HNHPF Hon Hai Precision
$6.27 /

-0.08 (-1.26%)

HAS Hasbro
$69.05 /

+0.09 (+0.13%)

GILD Gilead
$64.57 /

+2.24 (+3.59%)

F Ford
$12.21 /

+0.735 (+6.41%)

DPZ Domino's Pizza
$331.69 /

+15.34 (+4.85%)

CORZ Core Scientific
$1.60 /

+0.22 (+16.00%)

COMM CommScope
$11.04 /

+1.48 (+15.48%)

BBBY Bed Bath & Beyond
$6.43 /

+0.44 (+7.35%)

BABA Alibaba
$84.22 /

+3.82 (+4.75%)

BA Boeing
$132.52 /

+6.49 (+5.15%)

AYI Acuity Brands
$169.74 /

+10.35 (+6.49%)

AXTI AXT Inc.
$5.72 /

-1.28 (-18.29%)

AMZN Amazon.com
$122.53 /

+6.62 (+5.71%)

AEP American Electric
$90.39 /

+2.16 (+2.45%)

AAPL Apple
$145.18 /

+2.735 (+1.92%)

UBER Uber
$28.53 /

+1.84 (+6.89%)

TWTR Twitter
$45.40 /

+2.81 (+6.60%)

TSLA Tesla
$251.33 /

+9.055 (+3.74%)

RIVN Rivian Automotive
$35.75 /

+3.865 (+12.12%)

POSH Poshmark
$17.64 /

+2.07 (+13.29%)

PARA Paramount
$19.99 /

+0.37 (+1.89%)

MU Micron
$54.68 /

+2.98 (+5.76%)

HAS Hasbro
$69.05 /

+0.09 (+0.13%)

GILD Gilead
$64.57 /

+2.24 (+3.59%)

F Ford
$12.21 /

+0.735 (+6.41%)

DPZ Domino's Pizza
$331.69 /

+15.34 (+4.85%)

CORZ Core Scientific
$1.60 /

+0.22 (+16.00%)

BBBY Bed Bath & Beyond
$6.43 /

+0.44 (+7.35%)

BABA Alibaba
$84.22 /

+3.82 (+4.75%)

BA Boeing
$132.52 /

+6.49 (+5.15%)

AMZN Amazon.com
$122.53 /

+6.62 (+5.71%)

AAPL Apple
$145.18 /

+2.735 (+1.92%)

Options
Bed Bath & Beyond call volume above normal and directionally bullish » 10:05
10/04/22
10/04
10:05
10/04/22
10:05
BBBY

Bed Bath & Beyond

$6.42 /

+0.43 (+7.18%)

Bullish option flow…

Bullish option flow detected in Bed Bath & Beyond with 42,355 calls trading, 2x expected, and implied vol increasing over 7 points to 140.34%. 10/7 weekly 7 calls and Nov-22 15 calls are the most active options, with total volume in those strikes near 12,300 contracts. The Put/Call Ratio is 0.23. Earnings are expected on January 5th.

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$6.42 /

+0.43 (+7.18%)

BBBY Bed Bath & Beyond
$6.42 /

+0.43 (+7.18%)

09/30/22 Odeon Capital
Odeon upgrades Bed Bath & Beyond to Hold with things 'moving in right direction'
09/30/22 Odeon Capital
Bed Bath & Beyond upgraded to Hold from Sell at Odeon Capital
09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
BBBY Bed Bath & Beyond
$6.42 /

+0.43 (+7.18%)

BBBY Bed Bath & Beyond
$6.42 /

+0.43 (+7.18%)

BBBY Bed Bath & Beyond
$6.42 /

+0.43 (+7.18%)

BBBY Bed Bath & Beyond
$6.42 /

+0.43 (+7.18%)

On The Fly
Fly Intel: Pre-market Movers » 08:48
10/04/22
10/04
08:48
10/04/22
08:48
TSLA

Tesla

$242.24 /

-23.1 (-8.71%)

, POSH

Poshmark

$15.57 /

-0.11 (-0.70%)

, ADEA

Adeia

$7.19 /

+0.54 (+8.12%)

, EXEL

Exelixis

$16.36 /

+0.68 (+4.34%)

, BBBY

Bed Bath & Beyond

$5.99 /

-0.12 (-1.96%)

, RIVN

Rivian Automotive

$31.89 /

-1.025 (-3.11%)

, AYI

Acuity Brands

$159.51 /

+1.51 (+0.96%)

, KALV

KalVista

$14.24 /

-0.285 (-1.96%)

, RCKT

Rocket Pharmaceuticals

$15.49 /

-0.49 (-3.07%)

, AXTI

AXT Inc.

$7.00 /

+0.29 (+4.32%)

Check out this morning's…

ShowHide Related Items >><<
TSLA Tesla
$242.24 /

-23.1 (-8.71%)

RIVN Rivian Automotive
$31.89 /

-1.025 (-3.11%)

RCKT Rocket Pharmaceuticals
$15.49 /

-0.49 (-3.07%)

POSH Poshmark
$15.57 /

-0.11 (-0.70%)

KALV KalVista
$14.24 /

-0.285 (-1.96%)

EXEL Exelixis
$16.36 /

+0.68 (+4.34%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

AYI Acuity Brands
$159.51 /

+1.51 (+0.96%)

AXTI AXT Inc.
$7.00 /

+0.29 (+4.32%)

ADEA Adeia
$7.19 /

+0.54 (+8.12%)

TSLA Tesla
$242.24 /

-23.1 (-8.71%)

10/04/22 Morgan Stanley
Morgan Stanley expects Tesla shares to give back recent relative strength
10/03/22 JPMorgan
Tesla price target raised to $153 from $137 at JPMorgan
10/03/22 Oppenheimer
Tesla should be bought on any weakness following Q3 deliveries, says Oppenheimer
10/03/22 Wedbush
Wedbush remains bullish onTesla as Q3 deliveries come up short
POSH Poshmark
$15.57 /

-0.11 (-0.70%)

10/04/22 Needham
RealReal may be target for acquisition after Poshmark, says Needham
10/04/22 Wedbush
Poshmark downgraded to Neutral from Outperform at Wedbush
08/15/22 Barclays
Poshmark upgraded to Overweight from Equal Weight at Barclays
07/27/22 MKM Partners
MKM assumes Poshmark with Neutral rating, cites near-term profitability concerns
ADEA Adeia
$7.19 /

+0.54 (+8.12%)

EXEL Exelixis
$16.36 /

+0.68 (+4.34%)

08/10/22 Cowen
Exelixis price target raised to $26 from $24 at Cowen
07/26/22 Piper Sandler
Exelixis price target raised to $32 from $30 at Piper Sandler
06/23/22 BMO Capital
Exelixis initiated with an Outperform at BMO Capital
05/19/22 Piper Sandler
Exelixis sold off on Cabometyx patent trial comments, says Piper Sandler
BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

09/30/22 Odeon Capital
Odeon upgrades Bed Bath & Beyond to Hold with things 'moving in right direction'
09/30/22 Odeon Capital
Bed Bath & Beyond upgraded to Hold from Sell at Odeon Capital
09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
RIVN Rivian Automotive
$31.89 /

-1.025 (-3.11%)

10/04/22 Truist
Rivian Automotive's affirmed FY22 production outweighs Q3 shortfall, says Truist
09/28/22 Truist
Truist starts 'diversified mobility powerhouse' Rivian Automotive at Buy
09/28/22 Truist
Rivian Automotive initiated with a Buy at Truist
09/28/22 RBC Capital
RBC cuts Rivian target, production forecasts but stays Outperform
AYI Acuity Brands
$159.51 /

+1.51 (+0.96%)

09/27/22 William Blair
Acuity survey shows waning impact from price hikes, says William Blair
07/01/22 Oppenheimer
Acuity Brands delivers 'strong organic beat' in Q3, says Oppenheimer
07/01/22 Baird
Acuity Brands price target raised to $190 from $188 at Baird
06/27/22 Credit Suisse
Acuity Brands price target lowered to $211 from $241 at Credit Suisse
KALV KalVista
$14.24 /

-0.285 (-1.96%)

06/08/22 Stifel
KalVista acute HAE market opportunity 'underappreciated,' says Stifel
11/10/21 Roth Capital
KalVista FDA meeting feedback 'quite positive,' says Roth Capital
RCKT Rocket Pharmaceuticals
$15.49 /

-0.49 (-3.07%)

09/30/22 Chardan
Rocket Pharmaceuticals price target raised to $65 from $62 at Chardan
09/30/22 Evercore ISI
Rocket Pharmaceuticals price target raised to $75 from $65 at Evercore ISI
09/27/22 UBS
Rocket Pharmaceuticals price target cut to $62, named new top SMID pick at UBS
09/21/22 Baird
Renovacor downgraded to Neutral from Outperform at Baird
AXTI AXT Inc.
$7.00 /

+0.29 (+4.32%)

10/04/22 B. Riley
AXT Inc. price target lowered to $6.50 from $8 at B. Riley
10/03/22 BWS Financial
AXT Inc. may have won spot in iPhone 14 Pro and Pro Max, says BWS Financial
06/27/22 Needham
AXT Inc. initiated with a Buy at Needham
04/29/22 Northland
AXT Inc. price target lowered to $12 from $15 at Northland
TSLA Tesla
$242.24 /

-23.1 (-8.71%)

RIVN Rivian Automotive
$31.89 /

-1.025 (-3.11%)

RCKT Rocket Pharmaceuticals
$15.49 /

-0.49 (-3.07%)

POSH Poshmark
$15.57 /

-0.11 (-0.70%)

KALV KalVista
$14.24 /

-0.285 (-1.96%)

EXEL Exelixis
$16.36 /

+0.68 (+4.34%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

AYI Acuity Brands
$159.51 /

+1.51 (+0.96%)

AXTI AXT Inc.
$7.00 /

+0.29 (+4.32%)

  • 04
    Oct
  • 10
    Nov
TSLA Tesla
$242.24 /

-23.1 (-8.71%)

RIVN Rivian Automotive
$31.89 /

-1.025 (-3.11%)

POSH Poshmark
$15.57 /

-0.11 (-0.70%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

TSLA Tesla
$242.24 /

-23.1 (-8.71%)

RIVN Rivian Automotive
$31.89 /

-1.025 (-3.11%)

RCKT Rocket Pharmaceuticals
$15.49 /

-0.49 (-3.07%)

POSH Poshmark
$15.57 /

-0.11 (-0.70%)

KALV KalVista
$14.24 /

-0.285 (-1.96%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

AYI Acuity Brands
$159.51 /

+1.51 (+0.96%)

AXTI AXT Inc.
$7.00 /

+0.29 (+4.32%)

TSLA Tesla
$242.24 /

-23.1 (-8.71%)

RIVN Rivian Automotive
$31.89 /

-1.025 (-3.11%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

ADEA Adeia
$7.19 /

+0.54 (+8.12%)

Recommendations
Carnival price target lowered to $6 from $7 at Morgan Stanley » 07:13
10/04/22
10/04
07:13
10/04/22
07:13
CCL

Carnival

$6.84 /

-0.18 (-2.56%)

, RCL

Royal Caribbean

$37.53 /

-0.375 (-0.99%)

, NCLH

Norwegian Cruise Line

$11.40 /

+0.04 (+0.35%)

Morgan Stanley analyst…

Morgan Stanley analyst Jamie Rollo lowered the firm's price target on Carnival to $6 from $7 and keeps an Underweight rating on the shares after cutting EPS forecasts 13%-21% following Q3 results that showed weakening pricing and higher than expected costs. Though his monthly agents survey is "mixed but better than a few months ago," he stays cautious on the cruise lines space, Rollo added.

ShowHide Related Items >><<
RCL Royal Caribbean
$37.53 /

-0.375 (-0.99%)

NCLH Norwegian Cruise Line
$11.40 /

+0.04 (+0.35%)

CCL Carnival
$6.84 /

-0.18 (-2.56%)

CCL Carnival
$6.84 /

-0.18 (-2.56%)

10/03/22 Susquehanna
Carnival price target lowered to $8 from $12 at Susquehanna
10/03/22 Credit Suisse
Carnival price target lowered to $22 from $29 at Credit Suisse
10/03/22 Barclays
Carnival price target lowered to $10 from $14 at Barclays
09/20/22 Truist
Carnival price target raised to $10 from $8 at Truist
RCL Royal Caribbean
$37.53 /

-0.375 (-0.99%)

09/20/22 Truist
Royal Caribbean price target lowered to $58 from $65 at Truist
09/19/22 Stifel
Royal Caribbean price target raised to $70 from $60 at Stifel
09/19/22 Barclays
Royal Caribbean price target raised to $61 from $55 at Barclays
NCLH Norwegian Cruise Line
$11.40 /

+0.04 (+0.35%)

09/20/22 Truist
Norwegian Cruise Line upgraded to Buy at Truist amid bookings increase
09/20/22 Truist
Norwegian Cruise Line upgraded to Buy from Hold at Truist
09/19/22 Barclays
Norwegian Cruise Line price target raised to $16 from $14 at Barclays
09/06/22 Stifel
Norwegian Cruise Line liquidity concerns 'seem overblown,' says Stifel
RCL Royal Caribbean
$37.53 /

-0.375 (-0.99%)

NCLH Norwegian Cruise Line
$11.40 /

+0.04 (+0.35%)

CCL Carnival
$6.84 /

-0.18 (-2.56%)

  • 21
    Jul
RCL Royal Caribbean
$37.53 /

-0.375 (-0.99%)

NCLH Norwegian Cruise Line
$11.40 /

+0.04 (+0.35%)

CCL Carnival
$6.84 /

-0.18 (-2.56%)

RCL Royal Caribbean
$37.53 /

-0.375 (-0.99%)

NCLH Norwegian Cruise Line
$11.40 /

+0.04 (+0.35%)

CCL Carnival
$6.84 /

-0.18 (-2.56%)

RCL Royal Caribbean
$37.53 /

-0.375 (-0.99%)

NCLH Norwegian Cruise Line
$11.40 /

+0.04 (+0.35%)

CCL Carnival
$6.84 /

-0.18 (-2.56%)

Periodicals
Bed Bath creditors working with Perella Weinberg ahead of bond talks, WSJ says » 06:26
10/04/22
10/04
06:26
10/04/22
06:26
BBBY

Bed Bath & Beyond

$5.99 /

-0.12 (-1.96%)

Some Bed Bath &…

Some Bed Bath & Beyond bondholders are working with Perella Weinberg Partners ahead of debt talks expected to be held with the company, The Wall Street Journal's Jodi Xu Klein and Andrew Scurria report. The company said last week it is considering launching a distressed exchange that would swap the outstanding bonds for new, longer-tenured debt or equity in the company, based on their trading prices. Reference Link

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

09/30/22 Odeon Capital
Odeon upgrades Bed Bath & Beyond to Hold with things 'moving in right direction'
09/30/22 Odeon Capital
Bed Bath & Beyond upgraded to Hold from Sell at Odeon Capital
09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

BBBY Bed Bath & Beyond
$5.99 /

-0.12 (-1.96%)

Monday
Recommendations
Walgreens Boots Alliance price target lowered to $32 from $41 at Evercore ISI » 08:28
10/03/22
10/03
08:28
10/03/22
08:28
WBA

Walgreens Boots Alliance

$31.41 /

-0.16 (-0.51%)

, RAD

Rite Aid

$4.94 /

-0.12 (-2.37%)

Evercore ISI analyst…

Evercore ISI analyst Elizabeth Anderson lowered the firm's price target on Walgreens Boots Alliance (WBA) to $32 from $41 and keeps an In Line rating on the shares after lowering her FY23 EPS estimate to $4.25 from $4.60 following Rite Aid's (RAD) report of fiscal Q2 results last week. She expects Walgreens to likely shares its FY23 outlook when the company reports on October 13 and expects the FY23 EPS "bridge to be messy," with the potential for an adjustment to the company's longer-term growth algorithm, Anderson tells investors.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$31.41 /

-0.16 (-0.51%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

WBA Walgreens Boots Alliance
$31.41 /

-0.16 (-0.51%)

09/22/22 Deutsche Bank
Walgreens Boots Alliance price target lowered to $38 from $44 at Deutsche Bank
07/11/22 Evercore ISI
Evercore cuts AmerisourceBergen to In Line on valuation, Walgreens overhang
07/08/22 JPMorgan
Walgreens Boots Alliance price target lowered to $45 from $52 at JPMorgan
07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

10/03/22 Deutsche Bank
Rite Aid price target lowered to $3 from $4 at Deutsche Bank
09/30/22 Evercore ISI
Rite Aid removed from 'TAP Outperform' list at Evercore ISI, target cut to $4.50
06/03/22 Deutsche Bank
Rite Aid price target raised to $4 from $2 at Deutsche Bank
04/21/22 Deutsche Bank
Deutsche Bank says 'just stop' with the Rite Aid takeover talk
WBA Walgreens Boots Alliance
$31.41 /

-0.16 (-0.51%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

WBA Walgreens Boots Alliance
$31.41 /

-0.16 (-0.51%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

WBA Walgreens Boots Alliance
$31.41 /

-0.16 (-0.51%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

WBA Walgreens Boots Alliance
$31.41 /

-0.16 (-0.51%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

Recommendations
Rite Aid price target lowered to $3 from $4 at Deutsche Bank » 07:12
10/03/22
10/03
07:12
10/03/22
07:12
RAD

Rite Aid

$4.94 /

-0.12 (-2.37%)

Deutsche Bank analyst…

Deutsche Bank analyst George Hill lowered the firm's price target on Rite Aid to $3 from $4 and keeps a Sell rating on the shares. Rite Aid reported fiscal Q2 results where the company's core pharmacy business "continues to erode," and improvements in the pharmacy benefit management segment "may prove short lived" as the company "stares down lower membership" in 2023 due to a client loss, Hill tells investors in a research note.

ShowHide Related Items >><<
RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

09/30/22 Evercore ISI
Rite Aid removed from 'TAP Outperform' list at Evercore ISI, target cut to $4.50
06/03/22 Deutsche Bank
Rite Aid price target raised to $4 from $2 at Deutsche Bank
04/21/22 Deutsche Bank
Deutsche Bank says 'just stop' with the Rite Aid takeover talk
04/18/22 Deutsche Bank
Rite Aid price target raised to $2 from $1 at Deutsche Bank
RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

RAD Rite Aid
$4.94 /

-0.12 (-2.37%)

Recommendations
Carnival price target lowered to $10 from $14 at Barclays » 06:23
10/03/22
10/03
06:23
10/03/22
06:23
CCL

Carnival

$7.02 /

-2.14 (-23.36%)

, RCL

Royal Caribbean

$37.91 /

-5.735 (-13.14%)

Barclays analyst Brandt…

Barclays analyst Brandt Montour lowered the firm's price target on Carnival (CCL) to $10 from $14 and keeps an Overweight rating on the shares following the "disappointing" Q3 results. The analyst dropped estimates saying Carnival's recovery curve pushes out versus Street expectations and that the company's near-term operating gap relative to Royal Caribbean (RCL) had widened. However, with forward underlying bookings "accelerating nicely and 2023 profits still largely intact," Montour sees "much more upside than downside at current levels" in Carnival shares.

ShowHide Related Items >><<
RCL Royal Caribbean
$37.91 /

-5.735 (-13.14%)

CCL Carnival
$7.02 /

-2.14 (-23.36%)

CCL Carnival
$7.02 /

-2.14 (-23.36%)

09/20/22 Truist
Carnival price target raised to $10 from $8 at Truist
07/22/22 Truist
Carnival price target lowered to $8 from $15 at Truist
07/21/22 Stifel
Carnival selloff 'coming for sure' as equity raise will cause panic, says Stifel
07/04/22 HSBC
HSBC says too early to call inflection point for Carnival
RCL Royal Caribbean
$37.91 /

-5.735 (-13.14%)

09/20/22 Truist
Royal Caribbean price target lowered to $58 from $65 at Truist
09/19/22 Stifel
Royal Caribbean price target raised to $70 from $60 at Stifel
09/19/22 Barclays
Royal Caribbean price target raised to $61 from $55 at Barclays
07/29/22 Wells Fargo
Royal Caribbean price target lowered to $58 from $81 at Wells Fargo
RCL Royal Caribbean
$37.91 /

-5.735 (-13.14%)

CCL Carnival
$7.02 /

-2.14 (-23.36%)

  • 21
    Jul
RCL Royal Caribbean
$37.91 /

-5.735 (-13.14%)

CCL Carnival
$7.02 /

-2.14 (-23.36%)

RCL Royal Caribbean
$37.91 /

-5.735 (-13.14%)

CCL Carnival
$7.02 /

-2.14 (-23.36%)

RCL Royal Caribbean
$37.91 /

-5.735 (-13.14%)

CCL Carnival
$7.02 /

-2.14 (-23.36%)

Friday
On The Fly
Short Report: Marathon Digital bears skeptical of bottom in stock price » 15:48
09/30/22
09/30
15:48
09/30/22
15:48
MARA

Marathon Digital

$10.94 /

+0.17 (+1.58%)

, RAD

Rite Aid

$5.03 /

-0.035 (-0.69%)

, ASAN

Asana

$22.49 /

+0.23 (+1.03%)

, SPCE

Virgin Galactic

$4.77 /

-0.105 (-2.16%)

, FAZE

FaZe Holdings

$9.45 /

+0.16 (+1.72%)

, BLUE

Bluebird Bio

$6.30 /

+0.58 (+10.14%)

Welcome to this week’s…

ShowHide Related Items >><<
SPCE Virgin Galactic
$4.77 /

-0.105 (-2.16%)

RAD Rite Aid
$5.03 /

-0.035 (-0.69%)

MARA Marathon Digital
$10.94 /

+0.17 (+1.58%)

FAZE FaZe Holdings
$9.45 /

+0.16 (+1.72%)

BLUE Bluebird Bio
$6.30 /

+0.58 (+10.14%)

ASAN Asana
$22.49 /

+0.23 (+1.03%)

MARA Marathon Digital
$10.94 /

+0.17 (+1.58%)

09/23/22 BTIG
Marathon Digital cut to Neutral at BTIG on bankruptcy of its hosting provider
09/23/22 BTIG
Marathon Digital downgraded to Neutral from Buy at BTIG
09/15/22 DA Davidson
Marathon Digital price target lowered to $22 from $30 at DA Davidson
08/23/22 Cowen
Marathon Digital price target raised to $9 from $7 at Cowen
RAD Rite Aid
$5.03 /

-0.035 (-0.69%)

09/30/22 Evercore ISI
Rite Aid removed from 'TAP Outperform' list at Evercore ISI, target cut to $4.50
06/03/22 Deutsche Bank
Rite Aid price target raised to $4 from $2 at Deutsche Bank
04/21/22 Deutsche Bank
Deutsche Bank says 'just stop' with the Rite Aid takeover talk
04/18/22 Deutsche Bank
Rite Aid price target raised to $2 from $1 at Deutsche Bank
ASAN Asana
$22.49 /

+0.23 (+1.03%)

09/23/22 Credit Suisse
Asana initiated with a Neutral at Credit Suisse
09/22/22 MoffettNathanson
Asana initiated with a Market Perform at MoffettNathanson
09/08/22 Citi
Asana price target raised to $24 from $23 at Citi
09/08/22 RBC Capital
Asana price target raised to $15 from $13 at RBC Capital
SPCE Virgin Galactic
$4.77 /

-0.105 (-2.16%)

09/09/22 Bernstein
Virgin Galactic downgraded to Underperform from Market Perform at Bernstein
08/18/22 BofA
Virgin Galactic price target lowered to $5 from $7 at BofA
08/05/22 Truist
Virgin Galactic downgraded to Sell from Hold at Truist
08/05/22 Truist
Virgin Galactic downgraded to Sell from Hold at Truist
FAZE FaZe Holdings
$9.45 /

+0.16 (+1.72%)

BLUE Bluebird Bio
$6.30 /

+0.58 (+10.14%)

09/27/22 Morgan Stanley
Vertex exa-cel filing timeline 'better than feared,' says Morgan Stanley
08/22/22 William Blair
'Sticker shock' may limit uptake of Bluebird's Zynteglo, says William Blair
08/17/22 BTIG
Bluebird's approval has positive read for Mustang Bio, says BTIG
08/17/22 Piper Sandler
Piper says FDA nod for Bluebird's beta-cel positive for Crispr's exa-cel
SPCE Virgin Galactic
$4.77 /

-0.105 (-2.16%)

RAD Rite Aid
$5.03 /

-0.035 (-0.69%)

MARA Marathon Digital
$10.94 /

+0.17 (+1.58%)

BLUE Bluebird Bio
$6.30 /

+0.58 (+10.14%)

ASAN Asana
$22.49 /

+0.23 (+1.03%)

RAD Rite Aid
$5.03 /

-0.035 (-0.69%)

MARA Marathon Digital
$10.94 /

+0.17 (+1.58%)

BLUE Bluebird Bio
$6.30 /

+0.58 (+10.14%)

SPCE Virgin Galactic
$4.77 /

-0.105 (-2.16%)

RAD Rite Aid
$5.03 /

-0.035 (-0.69%)

MARA Marathon Digital
$10.94 /

+0.17 (+1.58%)

FAZE FaZe Holdings
$9.45 /

+0.16 (+1.72%)

BLUE Bluebird Bio
$6.30 /

+0.58 (+10.14%)

ASAN Asana
$22.49 /

+0.23 (+1.03%)

SPCE Virgin Galactic
$4.77 /

-0.105 (-2.16%)

RAD Rite Aid
$5.03 /

-0.035 (-0.69%)

MARA Marathon Digital
$10.94 /

+0.17 (+1.58%)

FAZE FaZe Holdings
$9.45 /

+0.16 (+1.72%)

BLUE Bluebird Bio
$6.30 /

+0.58 (+10.14%)

ASAN Asana
$22.49 /

+0.23 (+1.03%)

Upgrade
Odeon upgrades Bed Bath & Beyond to Hold with things 'moving in right direction' » 14:55
09/30/22
09/30
14:55
09/30/22
14:55
BBBY

Bed Bath & Beyond

$6.19 /

+0.01 (+0.16%)

As previously reported…

As previously reported before the open, Odeon Capital analyst Alexander Arnold upgraded Bed Bath & Beyond to Hold from Sell with an unchanged price target of $7.50. There were "no real surprises" in the company's fiscal Q2 report and while Arnold contends that Bed Bath is "not out of the woods just yet," things "appear to be moving in the right direction." He has increased confidence that rescue financing secured in September gives Bed Bath "an adequate liquidity runway for the business to get back on the rails," but Arnold added in his note issued this morning that "the next couple of quarters will really tell the story."

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$6.19 /

+0.01 (+0.16%)

BBBY Bed Bath & Beyond
$6.19 /

+0.01 (+0.16%)

09/30/22 Odeon Capital
Bed Bath & Beyond upgraded to Hold from Sell at Odeon Capital
09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
09/01/22 Raymond James
Bed Bath & Beyond downgraded to Underperform from Market Perform at Raymond James
BBBY Bed Bath & Beyond
$6.19 /

+0.01 (+0.16%)

BBBY Bed Bath & Beyond
$6.19 /

+0.01 (+0.16%)

BBBY Bed Bath & Beyond
$6.19 /

+0.01 (+0.16%)

BBBY Bed Bath & Beyond
$6.19 /

+0.01 (+0.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.